InSphero Company

InSphero is a supplier of organotypic, biological, in vitro 3D microtissues for highly predictive drug testing.
Technology: COVID, Organoids
Industry: AgeTech, Providers
Headquarters: Schlieren, Zurich, Switzerland
Founded Date: 2009-01-01
Employees Number: 11-50
Funding Status: Late Stage Venture
Investors Number: 7
Total Funding: 35182726
Estimated Revenue: $10M to $50M
Last Funding Date: 2019-03-19
Last Funding Type: Grant

Visit Website
Register and Claim Ownership